The mikerk7’s Podcast

What does it take to strengthen FDA compliance, improve quality management, and identify regulatory risks before they become costly problems?

Join Mike Kuehne of ComplyFDA and Brette Travaglio, CEO of Quality Solutions Now, for a conversation centered on the challenges facing today's pharmaceutical, biotechnology, and medical device industries.

Together, they bring their industry perspectives to the critical relationship between regulatory compliance, quality management, operational performance, and risk mitigation.

Key topics explored in this conversation include:

FDA Regulatory Compliance: Understanding the challenges of maintaining compliance in an evolving regulatory environment.

Quality Management Systems: The importance of effective quality practices in FDA-regulated organizations.

Regulatory Risk Management: Recognizing potential weaknesses and understanding the value of proactive compliance strategies.

Pharmaceutical and Medical Device Compliance: Addressing quality and regulatory challenges across the life sciences industry.

Industry Perspectives: Exploring how experienced professionals approach compliance, organizational accountability, and continuous improvement.

Who Should Listen?

Quality Assurance Directors, Regulatory Affairs Professionals, Compliance Officers, Pharmaceutical Manufacturing Leaders, Medical Device Executives, and life sciences professionals responsible for quality systems and regulatory oversight.

Stay Ahead of Regulatory Risk

ComplyFDA helps FDA-regulated organizations strengthen inspection readiness, evaluate quality systems, and understand regulatory e

What does an FDA investigator see that pharmaceutical and medical device manufacturers might overlook?

In Part 1 of Life Science Intelligence Signals, presented by ComplyFDA, Mike sits down with Ricki Chase, former FDA Director of Investigations, to explore her career inside the agency and her transition into life sciences regulatory consulting.

Ricki shares firsthand experiences spanning FDA field investigations, medical device oversight, pharmaceutical manufacturing, biologics, dietary supplements, and regulatory leadership. From her early work supporting FDA activities through the State of Texas to leading investigators in Chicago, her career offers a distinctive perspective on the regulatory environment facing life sciences organizations.

In this episode, discover:

How Ricki began her career conducting FDA-related inspections and investigations.

What her experience across multiple FDA-regulated industries taught her about regulatory oversight.

How her responsibilities evolved from field investigator to investigations leadership.

Why transitioning from FDA enforcement to private-sector consulting required an entirely different approach.

The regulatory experience she now brings to organizations navigating quality and compliance challenges.

Who should listen?

Quality Assurance Directors, Regulatory Affairs Professionals, Compliance Officers, Manufacturing Leaders, Medical Device Executives, and pharmaceutical and biotechnology professionals responsible for FDA inspection readiness and quality systems.

Don't miss Part 2!

Mike and Ricki continue their conversation in Part 2, exploring additional perspectives on FDA oversight and the realities of regulatory compliance.

Stay Ahead of FDA Compliance Risks

Explore FDA enforcement intelligence, inspection readiness assessments, quality system benchmarking, and regulatory insights from ComplyFDA.

Visit: https://complyfda.com/

Subscribe to Life Science Intelligence Signals for more conversations connecting real-world regulatory experience with the challenges facing today's life sciences industry.

#FDACompliance #FDAInspection #RegulatoryAffairs #QualityAssurance #LifeSciences

Exploring AI-driven regulatory signal detection, why experienced organizations miss warning signs, and how asking sharper questions earlier puts leaders ahead.